Immuron (IMRN) Non Operating Income (2018 - 2023)
Immuron (IMRN) recorded quarterly Non Operating Income of $149501.0 in Q4 2023, up 201.59% quarter-over-quarter from $49571.0 in Q4 2022, and up 201.59% on a YoY basis from $49571.0 in Q4 2022.
Immuron (IMRN) Non Operating Income (2018 - 2023) Analysis & Trends
Immuron's Non Operating Income history runs 6 years deep, the most recent figure standing at $149501.0 for Q4 2023.
- In Q4 2023, Non Operating Income rose 201.59% year-over-year to $149501.0; the TTM figure through Dec 2023 stood at $199122.1 (up 301.45% YoY), while the FY2025 annual figure was $83324.2, down 60.32% from the prior year.
- Non Operating Income was $149501.0 for Q4 2023 at Immuron, up from $49571.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $149501.0 in Q4 2023 to a low of -$20.87 in Q4 2019.
- Historically, Non Operating Income has averaged $39820.2 across 5 years, with a median of $66.19 in 2021.
- The sharpest annual moves came in 2019 and 2022: Non Operating Income sank 153.51% in 2019, then surged 74793.02% in 2022.
- A 5-year view of Non Operating Income shows it stood at -$20.87 in 2019, then increased by 22.81% to -$16.11 in 2020, then jumped by 510.86% to $66.19 in 2021, then soared by 74793.02% to $49571.0 in 2022, then jumped by 201.59% to $149501.0 in 2023.
- The last three Non Operating Income figures came in at $149501.0 (Q4 2023), $49571.0 (Q4 2022), and $66.19 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 149,501.00 |
| Dec 31, 2022 | 49,571.00 |
| Dec 31, 2021 | 66.19 |
| Dec 31, 2020 | -16.11 |
| Dec 31, 2019 | -20.87 |
| Dec 31, 2018 | 39.00 |